SOMAVERT 20 mg, powder and solvent for solution for injection bottle
Active ingredients: Pegvisomant
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottlesous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SOMAVERT 20 mg, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre
- Marketing authorisation holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Mar 2004
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66553998CIP73622506CIP133400936225060Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PEGVISOMANTpoudre | 20 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.